Patients Experienced Pseudoprogression to Anti-PD1/PD-L1 Inhibitor Have Better Response Than Those Without in Lung Cancer

被引：0
|
作者：
Zhao, W. [1 ,2 ]
Zhou, F. [1 ,2 ]
Li, W. [2 ,3 ]
Qian, D. [1 ,2 ]
Zhang, J. [1 ,2 ]
Wu, F. [1 ,2 ]
Zhou, C. [1 ,2 ]
机构：
[1] Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China
[2] Tongji Univ, Thorac Canc Inst, Sch Med, Shanghai, Peoples R China
[3] Shanghai Pulm Hosp, Dept Radiol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Pseudoprogression; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01.10
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [1] Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer
    Garces, Alvaro H. Ingles
    Au, Lewis
    Mason, Robert
    Thomas, Jennifer
    Larkin, James
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (08) : 695 - 708
  • [2] The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
    Sui, Xinbing
    Ma, Junhong
    Han, Weidong
    Wang, Xian
    Fang, Yong
    Li, Da
    Pan, Hongming
    Zhang, Li
    ONCOTARGET, 2015, 6 (23) : 19393 - 19404
  • [3] The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer
    Zhang, Shuling
    Bai, Xueli
    Shan, Fengping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [4] PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
    Katerina Ancevski Hunter
    Mark A. Socinski
    Liza C. Villaruz
    Molecular Diagnosis & Therapy, 2018, 22 : 1 - 10
  • [5] PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
    Hunter, Katerina Ancevski
    Socinski, Mark A.
    Villaruz, Liza C.
    MOLECULAR DIAGNOSIS & THERAPY, 2018, 22 (01) : 1 - 10
  • [6] Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy
    Le Burel, Sebastien
    Champiat, Stephane
    Routier, Emilie
    Aspeslagh, Sandrine
    Albiges, Laurence
    Szwebel, Tali-Anne
    Michot, Jean-Marie
    Chretien, Pascale
    Mariette, Xavier
    Voisin, Anne-Laure
    Lambotte, Olivier
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (03) : 468 - 470
  • [7] Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
    Ikeda, Sadakatsu
    Goodman, Aaron M.
    Cohen, Philip R.
    Jensen, Taylor J.
    Ellison, Christopher K.
    Frampton, Garrett
    Miller, Vincent
    Patel, Sandip P.
    Kurzrock, Razelle
    NPJ GENOMIC MEDICINE, 2016, 1
  • [8] Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
    Sadakatsu Ikeda
    Aaron M Goodman
    Philip R Cohen
    Taylor J Jensen
    Christopher K Ellison
    Garrett Frampton
    Vincent Miller
    Sandip P Patel
    Razelle Kurzrock
    npj Genomic Medicine, 1
  • [9] Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations
    Dantoing, Edouard
    Piton, Nicolas
    Salaun, Mathieu
    Thiberville, Luc
    Guisier, Florian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [10] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Diggs, Laurence P.
    Hsueh, Eddy C.
    BIOMARKER RESEARCH, 2017, 5
12345